Loading...
Mixed results with baricitinib in biological-resistant adult-onset Still’s disease and undifferentiated systemic autoinflammatory disease
This clinical case series describes our experience with the use of Janus kinase 1/2 inhibitor baricitinib in two patients suffering from refractory adult-onset Still’s disease (AOSD) as well as in one case suffering from AOSD-like autoinflammatory disease in the context of myelodysplastic syndrome....
Na minha lista:
| Udgivet i: | RMD Open |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BMJ Publishing Group
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7425191/ https://ncbi.nlm.nih.gov/pubmed/32669454 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2020-001246 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|